The individual tumor comparison also showed that the CIN z-score was numerically higher in tumors that acquired EGFR-TKI resistance compared to tumors before EGFR-TKI treatment (−0.223 vs. 0.204, respectively, Figure 1F). This evidence concerns the gene EGFR and neoplasm.